's ROI from its second quarter of 2026 to the second quarter of 2017 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is 's ROI in the second quarter of 2026?
achieved a return on average invested assets (ROI) of 9.15 % in its second quarter of 2026, this is above SSRI's average return on investment of 0%.
s investments during the 12 months ending in the second quarter of 2026 are valued at $3 billion

ROI has improved compared to 8.08% in the third quarter of 2021, due to net income growth.

Within the sector achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the third quarter of 2021 at no. .

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2017) IV. Quarter
Y / Y Investment Change TTM	156.95 %	1469.99 %	-	-	-
Y / Y Net Income Change TTM	406.33 %	-	-	-	-
Investment (TTM) in Millions	4,027	3,904	3,941	3,942	5,080
Return On Investment (TTM)	9.15 %	8.08 %	7.89 %	7.88 %	4.64 %
SSRI's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-6.24 %	20.16 %	39.03 %	64.04 %	472.87 %
Seq. Net Income Change TTM	6.15 %	23.19 %	39.11 %	178.34 %	-
Net Income (TTM) in Millions	362	341	277	199	71

SSRI Company Profile >> Back to SSRI Roi Comparisons >> See Annual SSRI Return On Investment

Return On Investment SSRI's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
's II. Quarter Investments	$ 4,027 Millions	SSRI's Balance sheet
's II. Quarter Income	$ 92 Millions	Quarterly SSRI's Income Statement
SSRI's Income by Division		See SSRI's Income by Division

SSRI Annual Return On Investment	(Dec 31 2020) 2020	(Dec 31 2018) 2018	(Dec 31 2017) 2017
Total Investments in Millions	5,080	1,206	0	0	0
Y / Y Investment Growth	321.14 %	-	-	-	-
Net Income in Millions	157	0	71	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	3.09 %	-0 %	-	-	-

Annual Roi Comment

In the fiscal year 2020 ROI improved to 3.09 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Industry Roi Trends and Statistics
Sector Return On Investment Statistics
Roi Trends for overall market
SSRI's Roi Ratio versus Industry, Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SSRI's Competitors
Subscribers only: Roi for 's Suppliers
Subscribers only: Return On Investment for SSRI's Customers

Other Ratios
SSRI's Roa	SSRI's Inventory Turnover Ratio	SSRI's Growth Rates	SSRI's Dividend Statistics
	SSRI's Profitability Ratios	SSRI's Asset Turnover Ratio	SSRI's Dividend Growth
SSRI's Roe	SSRI's Valuation Ratios	SSRI's Financial Strength Ratios	SSRI's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Sector	ROI
Gladstone Investment Corporationde	13.83 %
Chicago Atlantic Bdc Inc	9.15 %
Hercules Capital Inc	8.26 %
Main Street Capital Corporation	8.01 %
Msc Income Fund Inc	7.23 %
Trinity Capital Inc	5.57 %
Green Thumb Industries Inc.	5.34 %
Gladstone Capital Corp	5.34 %
Capital Southwest Corporation	5.26 %
Triplepoint Venture Growth Bdc Corp	4.91 %
Fidus Investment Corporation	4.66 %
Ares Capital Corporation	3.14 %
Whitehorse Finance inc	2.83 %
Blue Owl Technology Finance Corp	2.58 %
Sixth Street Specialty Lending Inc	2.57 %
Bain Capital Specialty Finance Inc	2.42 %
Phenixfin Corporation	2.32 %
Stellus Capital Investment Corp	2.28 %
Blackstone Secured Lending Fund	2.09 %
Prospect Capital Corp	2.06 %

Date modified: 2026-10-15T05:23:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.